International Workshop on NASH Biomarkers 2016

Related Enduring Materials

Enduring Materials

Session 1: Biomarker development -

Need for Biomarker Development in Non-Alcoholic Fatty Liver Disease

Eric Lefebvre, MD

Tobira Therapeutics Inc. , USA

Slide set

Principles of Biomarker Development

Margery Connelly, PhD, MBA

LabCorp (LipoScience), USA

Slide set

Biomarkers: what can be learned from type 2 diabetes

Manu Chakravarthy, MD, PhD

Eli Lilly & Co , USA

Slide set

Defining the gold standard in Biomarker Validation in NAFLD

Arun Sanyal, MD, MBBS

Virginia Commonwealth University Richmond, United States

Slide set

O_01 - Novel Method for Measuring Hepatic Collagen Turnover Rate in Nonalcoholic Fatty Liver Disease (NAFLD): Comparison of Blood and Liver Biopsy Biomarkers of Fibrogenesis (Not available)

Dr. M. Hellerstein

University of California, Berkeley , USA

O_02 - Performance of non-invasive tests in the staging of fibrosis in patients with NAFLD: interim results of a prospective multicentre study

Dr. P. Eddowes

University of Birmingham , United Kingdom

Slide set

Session 2: NAFLD Biomarkers -

Lipid and Bile acids as NAFLD-related biomarkers

Puneet Puri, MBBS, MD

Virginia Commonwealth University, USA

Slide set

Proteomics-based biomarker discovery in NAFLD

Naga Chalasani, MD

Indiana University Department of Medicine , USA

Slide set

Circulating nucleic acid-based biomarkers in NAFLD (Not available)

Dean Hum

Genfit , France

Study Design and endpoints in Omics-based biomarker studies

Stephen Williams, MD, PhD

SomaLogic , USA

Slide set

Session 3: Biomarkers for special patient populations -

Biomarker development in pediatric NAFLD: special challenges in a special population

Saul Karpen, MD, PhD

Emory University School of Medicine , USA

Slide set

Potential approach to identify the NAFLD patient who will develop HCC

Yujin Hoshida, MD, PhD

Icahn School of Medicine at Mount Sinai , USA

Slide set

Session 4: The role of diagnostics -

Simple laboratory based indices

Ray Kim, MD

Stanford University Medical Center , USA

Slide set

Dynamic measurement of physiologic functions: any role in NASH diagnostics

Stephen Previs, MD

Merck & Co , USA

Slide set

Microbiome: diagnostic considerations

Patrick Gillevet

George Mason University , USA

Slide set

O_07 - Early Changes in Plasma Adiponectin Identify Future Responders to Pioglitazone Therapy in Nonalcoholic Steatohepatitis (NASH) (Not available)

Dr. K. Cusi

University of Florida , USA

O_03 - A non-invasive lipidomic test accurately discriminates NASH from steatosis: a blind validation study

Dr. T. Montgomery

OWL Metabolomics , USA

Slide set

Session 5: Imaging strategies -

Noninvasive imaging methods for assessment of liver damage in NASH

Bachir Taouli, MD

Icahn School of Medicine at Mount Sinai , USA

Slide set

Methods of MR fat quantification and their pros and cons

Michael Middleton, MD, PhD

UC San Diego , USA

Slide set

LiverMultiScan – quantitative MR imaging for NASH

Rajarshi Banerjee

Perspectum Diagnostics , United Kingdom

Slide set

NASH and Fibroscan

Raj Vuppalanchi, MD

Indiana University School of Medicine , USA

Slide set

O_04 - Blood-based Protein Biomarkers of NASH

Dr. S. Williams

SomaLogic, Inc. , USA

Slide set

O_05 - Validation of multiparametric MRI in the assessment and staging of non-alcoholic fatty liver disease

Dr. P. Eddowes

University of Birmingham , United Kingdom

Slide set

O_06 - Longitudinal changes in FIB-4 and improvement in fibrosis stage with obeticholic acid: A secondary analysis of FLINT Trial

Dr. A. Sanyal

Intercept Pharmaceuticals , USA

Slide set

Session 6: Next steps in biomarkers development -

Quantitative measures of liver health

Grey Everson, MD

University of Colorado Denver , USA

Slide set

Overview

Welcome

We are pleased to look back on a very succesful 1st International Workshop on NASH Biomarkers, held in Washington, DC, USA on 29-30 April 2016.

Over 120 people attended the workshop and The Steering Committee and the organizing secretariat would like to thank the speakers, chairs and all participants for their contribution to this meeting! In particular we would like to thank our workshop sponsors. Without their financial contribution this workshop would not have been made possible.

Yours sincerely,

The Steering Committee

Committees